XUANZHUBIO-B (02575.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Oct28

Xuanzhu Biopharma's Introduced NG-350A Receives FDA Fast Track Designation

08:40

Oct21

Xuanzhu Bio-B Displays Mid-Stage Results of Pyrolisib Combined Treatment for Breast Cancer in Phase III Clinical Trial

22:29

Oct18

Multiple Biotech Companies Complete Financing and Technology Licensing, Innovative Pharma Debuts on Hong Kong Exchange

02:02

Oct6

XUANZHUBIO-B released FY2024 9 Months Earnings on October 6, 2025 (BJT), with actual revenue of HKD 25.09 M and EPS of HKD -0.8136

15:00

XUANZHUBIO-B released FY2024 earnings on October 6, 2025 (BJT), with actual revenue of HKD 32.58 M and EPS of HKD -1.3314

15:00

XUANZHUBIO-B released FY2024 Q2 earnings on October 6, 2025 (BJT), with actual revenue of HKD 8.612 M and EPS of HKD -0.1323

15:00

Schedules & Filings

Schedules

Filings

Oct15

IPO(CST)

Listing Price HKD 11.6

Oct6

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 9.792 M, Net Income -60.7 M, EPS -0.1346

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change